116 related articles for article (PubMed ID: 9113342)
1. The pharmacokinetics of butorphanol and its metabolites at steady state following nasal administration in humans.
Vachharajani NN; Shyu WC; Greene DS; Barbhaiya RH
Biopharm Drug Dispos; 1997 Apr; 18(3):191-202. PubMed ID: 9113342
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.
Davis GA; Rudy AC; Archer SM; Wermeling DP
Am J Health Syst Pharm; 2004 Feb; 61(3):261-6. PubMed ID: 14986556
[TBL] [Abstract][Full Text] [Related]
3. The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
Vachharajani NN; Shyu WC; Garnett WR; Morgenthien EA; Barbhaiya RH
Clin Pharmacol Ther; 1996 Sep; 60(3):283-94. PubMed ID: 8841151
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction between butorphanol nasal spray and oral metoclopramide in healthy women.
Vachharajani NN; Shyu WC; Barbhaiya RH
J Clin Pharmacol; 1997 Oct; 37(10):979-85. PubMed ID: 9505990
[TBL] [Abstract][Full Text] [Related]
5. Lack of pharmacokinetic interaction between butorphanol nasal spray and cimetidine.
Shyu WC; Barbhaiya RH
Br J Clin Pharmacol; 1996 Oct; 42(4):513-7. PubMed ID: 8904627
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of butorphanol nasal spray in patients with renal impairment.
Shyu WC; Morgenthien EA; Barbhaiya RH
Br J Clin Pharmacol; 1996 May; 41(5):397-402. PubMed ID: 8735680
[TBL] [Abstract][Full Text] [Related]
7. Multiple-dose phase I study of transnasal butorphanol.
Shyu WC; Pittman KA; Robinson D; Barbhaiya RH
Clin Pharmacol Ther; 1993 Jul; 54(1):34-41. PubMed ID: 8330463
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic method for the quantitative determination of butorphanol, hydroxybutorphanol, and norbutorphanol in human urine using fluorescence detection.
Willey TA; Duncan GF; Tay LK; Pittman KA; Farmen RH
J Chromatogr; 1994 Feb; 652(2):171-8. PubMed ID: 8006101
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, bioequivalence, and spray weight reproducibility of intranasal butorphanol after administration with 2 different nasal spray pumps.
Wermeling DP; Miller JL; Archer SM; Rayens MK; Rudy AC
J Clin Pharmacol; 2005 Aug; 45(8):969-73. PubMed ID: 16027409
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics of butorphanol after intravenous, intramuscular, and oral administration in Hispaniolan Amazon parrots (Amazona ventralis).
Guzman DS; Flammer K; Paul-Murphy JR; Barker SA; Tully TN
J Avian Med Surg; 2011 Sep; 25(3):185-91. PubMed ID: 22216718
[TBL] [Abstract][Full Text] [Related]
11. Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate.
Srinivas NR; Shyu WC; Upmalis D; Lee JS; Barbhaiya RH
J Clin Pharmacol; 1995 Apr; 35(4):432-7. PubMed ID: 7650235
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration.
Vachharajani NN; Shyu WC; Nichola PS; Boulton DW
Cephalalgia; 2002 May; 22(4):282-7. PubMed ID: 12100090
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of butorphanol tartrate in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus).
Riggs SM; Hawkins MG; Craigmill AL; Kass PH; Stanley SD; Taylor IT
Am J Vet Res; 2008 May; 69(5):596-603. PubMed ID: 18447789
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of butorphanol and its metabolites in human plasma by gas chromatography-electron capture negative-ion chemical ionization mass spectrometry.
Mulvana DE; Duncan GF; Shyu WC; Tay LK; Barbhaiya RH
J Chromatogr B Biomed Appl; 1996 Jul; 682(2):289-300. PubMed ID: 8844422
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse.
Knych HK; Casbeer HC; McKemie DS; Arthur RM
J Vet Pharmacol Ther; 2013 Feb; 36(1):21-30. PubMed ID: 22339417
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses.
Sellon DC; Monroe VL; Roberts MC; Papich MG
Am J Vet Res; 2001 Feb; 62(2):183-9. PubMed ID: 11212025
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and intramuscular bioavailability of a single dose of butorphanol in Asian elephants (Elephas maximus).
Tana LM; Isaza R; Koch DE; Hunter RP
J Zoo Wildl Med; 2010 Sep; 41(3):418-25. PubMed ID: 20945638
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horses.
Chiavaccini L; Claude AK; Lee JH; Ross MK; Meyer RE; Langston VC
J Vet Pharmacol Ther; 2015 Aug; 38(4):365-74. PubMed ID: 25484250
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of butorphanol in cats after intramuscular and buccal transmucosal administration.
Wells SM; Glerum LE; Papich MG
Am J Vet Res; 2008 Dec; 69(12):1548-54. PubMed ID: 19045999
[TBL] [Abstract][Full Text] [Related]
20. Validation and application of a sensitive assay for butorphanol in human plasma by high-performance liquid chromatography with tandem mass spectrometry detection.
Boulton DW; Duncan GF; Vachharajani NN
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jul; 775(1):57-62. PubMed ID: 12101060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
